Pure Global
NCT05065229

A Study of Agreement Between Oxygen Saturation Measured by Two Probes in Infants on the Neonatal Unit

University of Nottingham·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neonatal Disease
Drug/Device/Intervention
Oxygen saturation probe Mindray 520 N and Mindray 521 N
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Nottingham
Location
Derby, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Jul 15, 2021
End date
Jul 15, 2022
Enrollment
20 participants
Primary outcome

oxygen saturation of babies using Minday 520 N and Minday 521 N

Summary

On the neonatal unit in Derby, two types of probes are in routine use: Mindray 520 N and
 Mindray 521 N. Feedback from parents and staff show that there are concerns that the two
 probes given very different oxygen saturation readings and, often, do not agree with each
 other. This has raised concerns that infants' clinical care may be affected by the choice of
 probe. It is important to know if the two probes give similar results or not to ensure that
 infants get the appropriate monitoring and respiratory support as needed for good neonatal
 care. In this study, we will compare the reading made by the two probes and determine whether
 the readings of the two probes agree with each other and if any disagreement is such that
 clinical decision making is affected by the difference.

ICD-10 classifications
Neonatal aspiration syndrome, unspecifiedNeonatal comaNeonatal aspiration syndromesRespiratory condition of newborn, unspecifiedNeonatal diabetes mellitus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05065229
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05065229 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Nottingham and is currently Recruiting. The study focuses on Neonatal Disease. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.